DalsnaFinance

INVESTIGATION ALERT - The M&A Class Action Firm Is Investigating the Merger - RRC, SGRY, BOLT and PCRX - IS IT A FAIR DEAL FOR YOU?

Markets PR Newswire By PR Newswire 03 Nov 2026 17:19 1 min read
INVESTIGATION ALERT - The M&A Class Action Firm Is Investigating the Merger - RRC, SGRY, BOLT and PCRX - IS IT A FAIR DEAL FOR YOU?

NEW YORK, Nov. 3, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. We are...

Covered in this story

Range Resources RRC$54.47+0.00% Surgery Partners Inc SGRY$23.19+0.30% Bolt Biotherapeutics BOLT$6.35+1.70% Pacira Biosciences Inc PCRX$36.40-0.01% NOV NOV$18.81+0.67% TOP Financial Group TOP$10.87+0.09%

Analyst targets on Range Resources

Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.

Call it yourself

No member calls on $RRC yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.

Make the first call on Range Resources →
Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.